Update on overseas clinical trials progress of novel adjuvant COVID-19 vaccine ReCOV

/PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that positive results...

Related Keywords

China ,Taizhou ,Jiangsu ,Philippines ,United Arab Emirates ,Hong Kong , ,Stock Exchange Of Hong Kong ,Jiangsu Recbio Technology Co Ltd ,Press Release ,Stock Exchange ,Hong Kong Limited ,Jiangsu Recbio Technology Co ,Td ,